PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.\', \'Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.\', \'MS Applied Information and Management Sciences, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.\', \'BIOQUAL, Inc.; Rockville, Maryland, United States of America.\', \'Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.\', \'Center for Structural Biology, National Cancer Institute, Frederick, Maryland, United States of America.\', \'Department of Microbiology, University of Washington, Seattle, Washington, United States of America.\', \'Department of Medicine, University of Washington, Seattle, Washington, United States of America.\', \'Department of Global Health, University of Washington, Seattle, Washington, United States of America.\', \'Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.ppat.1009701
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34551020
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all